The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Inkster, Ian, Mr.
    Consultant born in November 1983
    Individual (1 offspring)
    Officer
    2021-08-02 ~ now
    OF - Director → CIF 0
  • 2
    85, Great Portland Street, London, England
    Active Corporate (1 parent, 2 offsprings)
    Equity (Company account)
    Retained earnings (accumulated losses)
    -2,579,773 GBP2024-03-31
    Person with significant control
    2020-11-02 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
Ceased 2
  • 1
    Cresniov, Alexei
    Director born in September 1988
    Individual (1 offspring)
    Officer
    2020-11-02 ~ 2022-10-05
    OF - Director → CIF 0
  • 2
    Buvailo, Andrii, Dr
    Director born in February 1985
    Individual (1 offspring)
    Officer
    2020-11-02 ~ 2021-12-30
    OF - Director → CIF 0
parent relation
Company in focus

DEEP PHARMA INTELLIGENCE LTD

Standard Industrial Classification
62090 - Other Information Technology Service Activities
Brief company account
Intangible Assets
294,233 GBP2024-03-31
222,125 GBP2023-03-31
Fixed Assets
294,233 GBP2024-03-31
222,125 GBP2023-03-31
Debtors
4,933 GBP2024-03-31
2,963 GBP2023-03-31
Cash at bank and in hand
151 GBP2024-03-31
1,482 GBP2023-03-31
Current Assets
5,084 GBP2024-03-31
4,445 GBP2023-03-31
Net Current Assets/Liabilities
-313,161 GBP2024-03-31
-207,540 GBP2023-03-31
Total Assets Less Current Liabilities
-18,928 GBP2024-03-31
14,585 GBP2023-03-31
Net Assets/Liabilities
-18,928 GBP2024-03-31
14,585 GBP2023-03-31
Equity
Called up share capital
10,000 GBP2024-03-31
10,000 GBP2023-03-31
Retained earnings (accumulated losses)
-28,928 GBP2024-03-31
4,585 GBP2023-03-31
Average Number of Employees
12023-04-01 ~ 2024-03-31
12022-04-01 ~ 2023-03-31
Intangible Assets - Gross Cost
Development expenditure
326,926 GBP2024-03-31
246,806 GBP2023-03-31
Intangible Assets - Accumulated Amortisation & Impairment
Development expenditure
32,693 GBP2024-03-31
24,681 GBP2023-03-31
Intangible Assets - Increase From Amortisation Charge for Year
Development expenditure
8,012 GBP2023-04-01 ~ 2024-03-31
Intangible Assets
Development expenditure
294,233 GBP2024-03-31
222,125 GBP2023-03-31
Trade Debtors/Trade Receivables
Current
3,418 GBP2024-03-31
1,762 GBP2023-03-31
Trade Creditors/Trade Payables
Current
12,735 GBP2024-03-31
21,268 GBP2023-03-31
Other Taxation & Social Security Payable
Current
-18,666 GBP2024-03-31
-36,614 GBP2023-03-31

  • DEEP PHARMA INTELLIGENCE LTD
    Info
    Registered number 12987888
    63-66 Hatton Garden, 5th Floor, Suite 23, London EC1N 8LE
    Private Limited Company incorporated on 2020-11-02 (4 years 8 months). The company status is Active.
    The last date of confirmation statement was made at 2024-09-14
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.